Purinomia Biotech provides biologicals and small molecule development to target key ectonucleotidases for the treatment of diseases.
Purinomia Biotech has raised $1.0M in total funding. The most recent round was Debt Financing. The last funding was announced in June 2024.
Purinomia Biotech is headquartered in Woburn, United States.
Purinomia Biotech provides biologicals and small molecule development to target key ectonucleotidases for the treatment of diseases.
Purinomia Biotech is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Purinomia Biotech — Funding & Investors." VCBacked, June 7, 2024, https://www.vcbacked.co/company/purinomia-biotech. Accessed August 14, 2026.
VCBacked. (2024). Purinomia Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/purinomia-biotech
{{cite web |title=Purinomia Biotech — Funding & Investors |url=https://www.vcbacked.co/company/purinomia-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated